Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by goldtech

PMN

RE:RE:RE:RE:Failure rate

This is what they will disclose and in addition, the increase in dosages...

6 hours ago

PMN

RE:RE:Failure rate

I agree with you on the financing statement and if they do a financing before...

8 hours ago

PMN

Failure rate

It takes 10 to 15 years and around US$1 billion to develop one successful...

10 hours ago

PMN

RE:RE:RE:RE:Risk / Reward

Simply put we contend that only targeting toxic oligomers can you have the...

1 day ago

PMN

Financing and inept Board

Yes M101 I agree the common sense factor has not been exhibited with this...

1 day ago

PMN

RE:RE:Risk / Reward

ARIA-E is a factor in safety and any brain bleeding is reported in this study...

1 day ago

PMN

Risk / Reward

So in about 5 weeks from now we will see that PMN310 has no Aria-E and can...

1 day ago

PMN

FDA to approve lillies Donanemab

The rates of brain swelling and/or bleeding due to ARIA in clinical...

1 day ago

PMN

The bottom line

Abstract A large body of clinical and nonclinical evidence supports the...

3 days ago

PMN

Toxic oligomer hypothesis

Why is it we don't get any credit for PMN310? Simple, it has been decades...

6 days ago

PMN

TOXIC OLIGOMERS / JUNE DATA

The incidence of Alzheimer's disease (AD) is growing every day and...

9 days ago

PMN

Prothena

Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation...

9 days ago

PMN

1A Results/Market Awareness

When the 1A results are released in June the market will begin to put us on...

10 days ago

PMN

RE:RE:The only scenario

Partnership, joint venture, collaboration, call it what you want but if we...

12 days ago

PMN

The only scenario

There is only two outcomes, success with the antibody or failure, end of...

12 days ago

PMN

Bottom line

So if we assume that the timeline and present data is correct , then by June...

12 days ago

PMN

No News

This company has never ever had the stock acumen needed to attract...

13 days ago

PMN

Conferences

They said there was going to be the vaccinations results announced at the...

April 20, 2024

PMN

Phase 1A

If they do a cheap financing before positive results from the 1A study then...

April 17, 2024

PMN

Smells

Smells like another manipulated financing in the works. They never get this...

April 17, 2024

1 2 3 4 5 6 7 8 9 10 11 Next

Featured Company

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd V.VM

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ... view more »